For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
If incorrect, please enter your country/region into the box below, to view site information related to your country/region.
Don't have an account?
Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.
Create custom solutions with us
Partner with us
Access advice and support for any research roadblock
View support hub
Your experiments laid out step by step
Full event breakdown with abstracts, speakers, registration and more
View global event calendar
View all pathways
View all interactive pathways
The PD-1/PD-L1 pathway has shown promising clinical success as a cancer immunotherapy target. Learn how this pathway may lead to the next breakthrough.
Whether you're looking to measure PD-L1, PD1 or CTLA-4, browse our range of immuno-oncology ELISA kits and matched antibody pairs.
Learn more about our highly validated set of reagents for PD-1/PD-L1 pathway including Primary antibodies, conjugated primaries, and ELISA kits.
Find the antibodies and assay kits you need to unlock the power of immuno-oncology. Includes products for PD-L1, PD-1, CTLA4 and CXCR4.
We discuss PD-L1 antibody clones and their variations in sensitivity for therapeutic and detection applications.
Compare our top recombinant PD-L1 antibody clones.
Highly characterized in IHC, Flow Cyt and ICC/IF and knockout (KO) validated.
We combined our popular RabMAb PD-L1 antibody [clone 28-8] with our 90-minute SimpleStep ELISA protocol to create a kit with nearly 2-fold higher sensitivity than the main competitor’s published results.
Download detailed protocols for PD-L1 [28-8] staining using popular automated immunohistochemistry platforms.
Simple but sophisticated: assay kits to help you analyze the metabolism of sugars, lipids, amino acids, intermediaries, alcohols, and more.